StocksAkornAKRX

AKRX

Akorn

0.0270 0 (0%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
0.1609
B
0.1645

Overview

Prev Close0.0270
Day's Range0.0909 - 0.1124
52 Week Range0.0824 - 1.2700
Average Volume (3m)3.84M
1-Year Return-90.23%
Beta1.3778
Market Cap3.6M
P/E Ratio30.24
Revenue663.5M
EPS-2.7894
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.723/12/201905/03/202013/05/20201.00002.00003.00004.0000
Chart times in UTC
Industry Pharmaceuticals Major
CEO Douglas S. Boothe, MBA
Employees 2,227

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2019: Akorn's revenues decreased by 1.67% and amounted to 682.43M. Net income increased by 43.58% to -226.77M. Net assets decreased by NaN to 234.29M and EPS decreased from N/A to -1.80.
AKRX's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
34.03%
Net Profit Margin
-12.45%
Operating Margin
-13.43%
Return On Investment
-20.22%
06/19
09/19
12/19
03/20
Total Revenue
178.06M
176.24M
162.26M
204.69M
Gross Profit
67.98M
62.03M
50.43M
88.4M
Operating Income
-12.5M
-2.86M
-44.31M
13.54M
Net Income
-111.6M
47.67M
-80.66M
-256.73M